India Life Science & Analytical Instruments Market is predicted to reach USD 0.72 billion at a CAGR of 11.64% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global India Life Science & Analytical Instruments Market”.

The India life science & analytical instruments market is estimated to register a CAGR of 11.64% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the India Life Science & Analytical Instruments Market— Getinge (Sweden), Shimadzu Corporation (Japan), Sartorius AG (Germany), Pharmalab India Private Limited (India), Thermo Fisher Scientific Inc (US), Agilent Technologies Inc (US), QIAGEN (Germany), PerkinElmer, Inc. (US), Bio-Rad Laboratories, Inc. (US), and STERIS plc (Ireland).

Market Highlights

The India Life Science & Analytical Instruments market is expected to register a CAGR of 11.64% during the forecast period and is estimated to reach USD 0.72 billion by 2032.

The term "life science & analytical instruments" describes a broad category of highly advanced apparatus and instruments used in many scientific domains, such as biology, chemistry, and medicine. These tools are intended for use in the analysis of chemical and biological materials as well as in the study of the composition and operation of living things.

Rising demand for analytical instruments in different sectors is one of the major factors driving the growth of the India life science and analytical instruments market. Likewise, increasing pharmaceutical R&D investment and rising adoption of technologically based life sciences and analytical instruments are further fueling the growth of the India market during the review period. However, the dearth of skilled professionals is expected to hamper the growth of the India market. Nevertheless, untapped opportunities, such as a growing geriatric population and an increasing population, are anticipated to create lucrative opportunities for the players operating in the India market.

Access full report @ https://www.marketresearchfuture.com/reports/india-life-science-analytical-instruments-market-21631

Segment Analysis

The India life science & analytical instruments market has been segmented based on instrument type, application, and end user.

On the basis of instrument type, the market is segmented into sterilizers, bioreactors, washers, isolators, aseptic transfer equipment, and others. The others segment held the largest market share in 2022, and bioreactors is the fastest-growing segment during the forecast period. The others segment includes sterile filters, sterile tubing and hoses and aseptic connectors. The high productivity, process control and monitoring, and flexibility in production are some driving factors for the segment. Moreover, the single-use bioreactors are designed for one-time use in the cultivation of cells or microorganisms.

On the basis of the application, the market is segmented into clinical and diagnostics, research, and others. clinical and diagnostics, research, and others. The research segment held the largest market share in 2022, and clinical and diagnostics is the fastest-growing segment during the forecast period. Increased public-private financing in genomic research, as well as the continued trend of laboratory automation and robotics, all contribute to a substantial proportion of the research applications market. Furthermore, the quickly expanding healthcare infrastructure, equipment, advanced technology, and skilled staff to perform complex tests all contribute to market growth.

On the basis of end user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others. The pharmaceutical & biotechnology industry is contributing significantly to the market's growth in India. The bioprocessing sector is emerging as a substantial player in the market under examination, with an increasing emphasis on pharmaceutical quality manufacturing. To widen their reach and cut operational expenses, the corporations have adopted a strategy of seeking regulatory approval from government bodies for their products and negotiating contracts and agreements.

Key Findings of the Study

• The India life science & analytical instruments market is expected to reach USD 0.72 billion by 2032, at a CAGR of 11.64% during the forecast period.


• Based on instrument type, the media segment was attributed to holding the largest market in 2022.


• Getinge (Sweden), Thermo Fisher Scientific Inc (US), Agilent Technologies Inc (US), PerkinElmer, Inc. (US), and Sartorius AG (Germany) are the key market players.